Credit: K KStock/Adobe stock

Although GLP-1 drugs have shown impressive results for weight loss, they are forcing employers to ask tough questions about whether to provide coverage.

“It’s a complicated picture in terms of how we would like to see our scarce health care dollars allocated,” said Zak Kornblum, Pharm.D., pharmacy clinical director for Marsh McLennan Agency. “Coverage of GLP-1s is not necessarily in-your-face obvious. It leads to the conversation of whether we want to pursue weight loss through drug products or something like a wellness program.”


NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2025 ALM Global, LLC. All Rights Reserved.